Cardiology Department, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France.
Cardinal Wyszynski National Institute of Cardiology, Warsaw, Poland.
J Am Coll Cardiol. 2021 Nov 30;78(22):2131-2143. doi: 10.1016/j.jacc.2021.09.864.
There were gaps between guidelines and practice when surgery was the only treatment for aortic stenosis (AS).
This study analyzed the decision to intervene in patients with severe AS in the EORP VHD (EURObservational Research Programme Valvular Heart Disease) II survey.
Among 2,152 patients with severe AS, 1,271 patients with high-gradient AS who were symptomatic fulfilled a Class I recommendation for intervention according to the 2012 European Society of Cardiology guidelines; the primary end point was the decision for intervention.
A decision not to intervene was taken in 262 patients (20.6%). In multivariate analysis, the decision not to intervene was associated with older age (odds ratio [OR]: 1.34 per 10-year increase; 95% CI: 1.11 to 1.61; P = 0.002), New York Heart Association functional classes I and II versus III (OR: 1.63; 95% CI: 1.16 to 2.30; P = 0.005), higher age-adjusted Charlson comorbidity index (OR: 1.09 per 1-point increase; 95% CI: 1.01 to 1.17; P = 0.03), and a lower transaortic mean gradient (OR: 0.81 per 10-mm Hg decrease; 95% CI: 0.71 to 0.92; P < 0.001). During the study period, 346 patients (40.2%, median age 84 years, median EuroSCORE II [European System for Cardiac Operative Risk Evaluation II] 3.1%) underwent transcatheter intervention and 515 (59.8%, median age 69 years, median EuroSCORE II 1.5%) underwent surgery. A decision not to intervene versus intervention was associated with lower 6-month survival (87.4%; 95% CI: 82.0 to 91.3 vs 94.6%; 95% CI: 92.8 to 95.9; P < 0.001).
A decision not to intervene was taken in 1 in 5 patients with severe symptomatic AS despite a Class I recommendation for intervention and the decision was particularly associated with older age and combined comorbidities. Transcatheter intervention was extensively used in octogenarians.
在主动脉瓣狭窄(AS)仅接受手术治疗的情况下,指南与实践之间存在差距。
本研究分析了 EORP VHD(欧洲观察性研究计划瓣膜性心脏病)II 调查中严重 AS 患者介入治疗的决策。
在 2152 名严重 AS 患者中,1271 名有高梯度 AS 的症状性患者根据 2012 年欧洲心脏病学会指南符合介入治疗 I 级推荐;主要终点是干预决策。
262 名患者(20.6%)决定不进行干预。多变量分析显示,决定不干预与年龄较大(每增加 10 岁,比值比 [OR]:1.34;95%CI:1.11 至 1.61;P = 0.002)、纽约心脏协会功能分级 I 和 II 级与 III 级(OR:1.63;95%CI:1.16 至 2.30;P = 0.005)、较高的年龄调整 Charlson 合并症指数(OR:每增加 1 分,1.09;95%CI:1.01 至 1.17;P = 0.03)和较低的跨主动脉平均梯度(OR:每降低 10mmHg,0.81;95%CI:0.71 至 0.92;P<0.001)相关。在研究期间,346 名患者(40.2%,中位年龄 84 岁,中位 EuroSCORE II [欧洲心脏手术风险评估系统 II] 3.1%)接受了经导管介入治疗,515 名患者(59.8%,中位年龄 69 岁,中位 EuroSCORE II 1.5%)接受了手术。决定不干预与干预相比,6 个月生存率较低(87.4%;95%CI:82.0 至 91.3 与 94.6%;95%CI:92.8 至 95.9;P<0.001)。
尽管有 I 级介入治疗推荐,但仍有 1/5 的严重有症状 AS 患者决定不进行干预,且该决定特别与年龄较大和合并症有关。经导管介入治疗在 80 岁以上人群中广泛应用。